|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52801517
???header.onlineuser??? :
566
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"gopa"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-06-01 |
Efficacy and safety of erdafitinib in patients with advanced or metastatic cholangiocarcinoma and FGFR alterations: Pooled analysis of RAGNAR and LUC2001 studies.
|
Pant;Shubham;Park;Oh, Joon;Su;Wu-Chou;Schuler;Martin, H.;Loriot;Yohann;Iyer;Gopa;Doi;Toshihiko;Qin;Shukui;Tabernero;Josep;Prenen;Hans;Folprecht;Gunnar;Winter;Helen;Molin, Dal;Zibetti, Graziela;Sweiti;Hussein;Najmi;Saltanat;Hammond;Constance;Liao;Huimin;Thomas;Shibu;Triantos;Spyros;Feng;Yin-Hsun |
| 國立成功大學 |
2024-02-1 |
Enfortumab vedotin (EV) in combination with pembrolizumab (P) versus chemotherapy in previously untreated locally advanced metastatic urothelial carcinoma (la/mUC): Subgroup analyses results from EV-302, a phase 3 global study
|
Heijden, Van Der;Simon, Michiel;Powles;Thomas;Gupta;Shilpa;Bedke;Jens;Kikuchi;Eiji;Wit, De;Ronald;Galsky;Matt, D.;Duran;Ignacio;Necchi;Andrea;Retz;Margitta;Yu;Evan, Y.;Hoffman-Censits;Jean, H.;Iyer;Gopa;Park;Hoon, Se;Su;Wen-Pin;Parmar;Hema;Guan;Xuesong;Gorla;Rao, Seema;Moreno, Homet;Blanca;Valderrama;Perez, Begona |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
